Soluble plasma proteins ST2 and CD163 as early biomarkers of nephropathy in Swedish patients with diabetes, 15–34 years of age: a prospective cohort study

Prognostic Value of Serial Measurements of Soluble Suppression of Tumorigenicity 2 and Galectin-3 in Ambulatory Patients With Chronic Heart Failure

(2016) Wayne L. Miller et al.   JOURNAL OF CARDIAC FAILURE

Progressive Renal Decline: The New Paradigm of Diabetic Nephropathy in Type 1 Diabetes

(2015) Andrzej S. Krolewski   DIABETES CARE

sST2 levels are associated with all-cause mortality in anticoagulated patients with atrial fibrillation

(2015) Juan A. Vílchez et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33

(2015) Geethani Bandara et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Rapid GFR decline is associated with renal hyperfiltration and impaired GFR in adults with Type 1 diabetes

(2015) Petter Bjornstad et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

The Tumor Necrosis Factor Superfamily Members TWEAK, TNFSF15 and Fibroblast Growth Factor-Inducible Protein 14 Are Upregulated in Proliferative Diabetic Retinopathy

(2015) Ahmed M. Abu El-Asrar et al.   OPHTHALMIC RESEARCH

CD163 interacts with TWEAK to regulate tissue regeneration after ischaemic injury

(2015) Hirokuni Akahori et al.   Nature Communications

Biomarkers of Renal Disease and Progression in Patients with Diabetes

(2015) Radovan Hojs et al.   Journal of Clinical Medicine

Predictors of Cardiovascular Autonomic Neuropathy in Patients with Type 1 Diabetes

(2015) Lucianne Righeti Monteiro Tannus et al.   Frontiers in Endocrinology

Increased Soluble ST2 Predicts Long-term Mortality in Patients with Stable Coronary Artery Disease: Results from the Ludwigshafen Risk and Cardiovascular Health Study

(2014) B. Dieplinger et al.   CLINICAL CHEMISTRY

Impact of HbA1c, Followed From Onset of Type 1 Diabetes, on the Development of Severe Retinopathy and Nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden)

(2014) Maria Nordwall et al.   DIABETES CARE

Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study

(2014)   Lancet Diabetes & Endocrinology

Effects of Visit-to-Visit Variability in Systolic Blood Pressure on Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes Mellitus

(2013) Jun Hata et al.   CIRCULATION

Relationship of Glycated Albumin to Blood Glucose and HbA1c Values and to Retinopathy, Nephropathy, and Cardiovascular Outcomes in the DCCT/EDIC Study

(2013) D. M. Nathan et al.   DIABETES

Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: A nationwide observational study from the Swedish National Diabetes Register

(2013) Maria K Svensson et al.   Diabetes & Vascular Disease Research

Renal Lesions Predict Progression of Diabetic Nephropathy in Type 1 Diabetes

(2013) M. L. Caramori et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The Macrophage-Specific Serum Marker, Soluble CD163, Is Increased in Obesity and Reduced After Dietary-Induced Weight Loss

(2013) Karen Fjeldborg et al.   Obesity

TWEAK: A New Player in Obesity and Diabetes

(2013) Joan Vendrell et al.   Frontiers in Immunology

Soluble CD163: a biomarker linking macrophages and insulin resistance

(2012) T. Parkner et al.   DIABETOLOGIA

Soluble CD163 is associated with body mass index and blood pressure in hypertensive obese Saudi patients

(2012) Nasser M. Al-Daghri et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Renal impairment and all-cause mortality in cardiovascular disease: effect modification by type 2 diabetes mellitus

(2012) Sharmini Selvarajah et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

IL-33/ST2 axis in inflammation and immunopathology

(2012) Marija Milovanovic et al.   IMMUNOLOGIC RESEARCH

Serum Levels of TWEAK and Scavenger Receptor CD163 in Type 1 Diabetes Mellitus: Relationship with Cardiovascular Risk Factors. A Case-Control Study

(2012) Gemma Llauradó et al.   PLoS One

Soluble ST2 Associates with Diabetes but Not Established Cardiovascular Risk Factors: A New Inflammatory Pathway of Relevance to Diabetes?

(2012) Ashley M. Miller et al.   PLoS One

Toll/Interleukin-1 receptor member ST2 exhibits higher soluble levels in type 2 diabetes, especially when accompanied with left ventricular diastolic dysfunction

(2011) Evangelos Fousteris et al.   Cardiovascular Diabetology

Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts

(2011) Ron T. Gansevoort et al.   KIDNEY INTERNATIONAL

Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients

(2011) Faramarz Ismail-Beigi et al.   KIDNEY INTERNATIONAL

Soluble CD163

(2011) Holger J. Møller   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Early Urinary Markers of Diabetic Kidney Disease: A Nested Case-Control Study From the Diabetes Control and Complications Trial (DCCT)

(2010) Elizabeth F.O. Kern et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Serum Soluble CD163 Predicts Risk of Type 2 Diabetes in the General Population

(2010) H. J. Moller et al.   CLINICAL CHEMISTRY

Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic Patients

(2010) S. E. Nielsen et al.   DIABETES CARE

Serum Soluble ST2

(2010) Robin A.P. Weir et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial

(2009) J. W. J. Beulens et al.   DIABETOLOGIA

Understanding and using sensitivity, specificity and predictive values

(2009) Rajul Parikh et al.   INDIAN JOURNAL OF OPHTHALMOLOGY